Vivani Medical (VANI) Stock
Small medical device company developing urology technologies. Here's the price, business snapshot, and what's worth knowing about Vivani Medical in October 2026.
Vivani Medical Inc (ticker VANI) is a small‑cap medical device company with a market capitalisation of around US$99.5m. Investors should know it operates in the healthcare sector developing and/or commercialising medical technologies; value is often driven by clinical progress, regulatory clearances and commercial partnerships. As a smaller company it typically has limited revenue visibility, greater share‑price volatility and dependence on successful trial outcomes and reimbursement decisions. Key factors to monitor include cash runway, management execution, any partnership or distribution agreements, and milestone announcements that could materially affect outlook. Be mindful of funding and dilution risk if additional capital is required. This is a general, educational overview — not personalised financial advice. Returns are not guaranteed and the stock may suit investors with a higher risk tolerance and a long‑term horizon.
Vivani Medical (VANI) Stock Forecast
Analyst price target, next 12 months
$5.63
+357.3% vs today's $1.23
Price range over the last 12 months
In the middle of its 12-month range
Analysts covering Vivani Medical have a consensus 12-month target of $5.63, above the current price of $1.23.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 30 Sep 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying VIVANI MEDICAL INC's stock with a target price of $5.63, indicating strong growth potential.
Financial Health
VIVANI MEDICAL INC has a modest cash flow and book value, indicating stable financial performance.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Clinical & Regulatory Catalysts
Progress in trials or approvals can be major price drivers, offering upside but also sharp downside if results disappoint.
Commercial Partnerships Matter
Distribution or manufacturing agreements can validate technology and support revenue growth, though contract execution may take time.
Small‑cap Market Dynamics
Smaller market capitalisation means higher volatility and liquidity risk; this stock may suit investors comfortable with swings and potential dilution.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
